Vistagen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2025 Earnings Conference Call June 17, 2025 5:00 PM ETCompany Participants. Cynthia Lynn Anderson - VP & Chief Financial Officer Mark Adrian McPartland ...

Operator: Good day, everyone, and thank you for standing by. Welcome to the Vistagen Therapeutics Fiscal Year-End 2025 ...

Goodenowe is not a medical doctor, but he does have a PhD in medical science with a focus on psychiatry. He’s a listed author ...

The inspector general had concluded that the FDA would need to increase inspections by more than 3,000 each year, in order to meet its goals. Under requirements laid out by Congress, ...

On Wednesday, FX renewed Welcome to Wrexham for a fifth season, as well as revealed new details about its spinoff series Necaxa (fka Bienvenidos a Necaxa), a partnership with Disney+ Latin America ...

FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” with biopharma leaders attending BIO in Boston.

Presented by Alliance for Pharmacy Compounding — The Food and Drug Administration commissioner has committed to reviewing the abortion drug mifepristone after previously stating he had no plans ...

Vaccines are one of the most successful public health tools in human history. In Wyoming and across the nation, they have prevented countless hospitalizations, permanent disabilities and early deaths.

The FDA rejected Stealth BioTherapeutics’ latest bid to market its proposed treatment for an ultra-rare genetic condition, though regulators have suggested a “path” toward accelerated approval.

Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues ...